Loading clinical trials...
Loading clinical trials...
Parkinson's disease is the second most common neurodegenerative disease affecting about 1-3% of population above 60 years. Recently, non-motor symptoms are getting more attention in PD management. The...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zagazig University
NCT07536022 · Parkinson's Disease
NCT07644013 · Multiple System Atrophy, Parkinson's Disease, and more
NCT07636720 · Parkinson's Disease and Parkinsonism, Dyssomnia
NCT06916507 · Parkinson's Disease
NCT07398157 · PD - Parkinson's Disease
National Liver Institute
Cairo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions